Sinovac Covid Vaccine to Be Reviewed by EMA

Sinovac, the Chinese company will be evaluated by the European Medicine Agency (EMA) under usual European Union (EU) standards for effectiveness, safety and quality.

Covid-19 vaccine developed by Chinese company Sinovac is under review by the European Medicine Agency (EMA) to win approval for usage in the bloc.

In a press statement on Tuesday, the EMA announced that the application for the vaccine was submitted by Italy-based Life'On S.r.l., Xinhua reported.

Covid-19 in Nepal: Cases and Deaths on Rise for 3rd Straight Day
Nepal's single day Covid-19 cases and deaths have soared so high amid an ongoing second wave of the pandemic in the country. This is the first time that the country's daily cases surpassed 8,000.

‘Sinovac, the Chinese company will be evaluated by the European Medicine Agency (EMA) under usual European Union (EU) standards for effectiveness, safety and quality.’

"The vaccine triggers the production of antibodies that target SARS-CoV-2, the virus that causes Covid-19, and may help protect against the disease," said the EMA.

The Chinese vaccine uses an inactivated form of the SARS-CoV-2, which cannot cause the disease. Once inoculated, the vaccinated person will start producing antibodies against the virus, hence becoming ready to fight the virus should contact be made later on, according to the EMA.

Sinovac will be evaluated with the usual European Union (EU) standards for effectiveness, safety and quality, said the agency.

Ayush App Treats Covid-19 Patients in Home Isolation
AYUSH Kavach App helps provide maximum benefits of the ancient and traditional health systems like Ayurveda which are affordable and accessible. It is helpful in treating patients in home isolation.

So far, four vaccines developed by BioNTech/Pfizer, Moderna, AstraZeneca and Johnson & Johnson, have been granted conditional marketing authorization.

Four other vaccines are under rolling review, including Sinovac, CureVac, Novavax and Sputnik V. A rolling review is a regulatory tool that the EMA uses to speed up the assessment of a promising medicine during a public health emergency.

Global Covid-19 Cases Reach 154.7 Million
Global Covid-19 caseload has reached 154.7 million and deaths have surged to more than 3.23 million. The US continues to be the worst-hit country with the world's highest number of cases and followed by India in the second place.

No EU country currently uses the Sinovac vaccine. However, EU-member Hungary has decided to vaccinate its population using the Sinopharm Covid-19 vaccine, another Chinese vaccine.

Nano-Niclosamide Has Potential to Treat COVID-19
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat COVID-19.

Source-IANS